The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Benicar was produced by Daiichi Sankyo.
The restricting comes as Daiichi Sankyo faces the loss of patent protection in the US for Benicar (olmesartan), a $2.4bn-a-year product used to treat high blood pressure. .
$2.4bn-a-year high blood pressure drug Benicar (olmesartan) is due to succumb to generic competition in the coming months and it is not uncommon for a big brand to ... The company will need late-stage pipeline candidates to deliver if it is to ride out
several of its products, including high blood pressure treatment Benicar (olmesartan) and various combinations of the drug with other antihypertensive agents.
Daiichi Sankyo's Benicar (olemesartan).
In other studies, the combination was compared to azilsartan medoxomil co-administered with the generic diuretic hydrochlorothiazide and with a fixed-dose combination of Daiichi Sankyo's Benicar (olmesartan) and hydrochlorothiazide. ... Phase III
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...